Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

94 filings reported holding CTKB - Cytek Biosciences, Inc. - Common Stock - $0.001 par value as of Q1 2024.
Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 76.2M shares of 128M outstanding shares and own 59.58% of the company stock.
Largest 10 shareholders include BlackRock Inc. (17.4M shares), BROWN CAPITAL MANAGEMENT LLC (12M shares), VANGUARD GROUP INC (12M shares), RA CAPITAL MANAGEMENT, L.P. (6.81M shares), HHLR ADVISORS, LTD. (6.66M shares), STATE STREET CORP (4.12M shares), NEW YORK STATE COMMON RETIREMENT FUND (2.95M shares), GEODE CAPITAL MANAGEMENT, LLC (2.51M shares), DIMENSIONAL FUND ADVISORS LP (1.38M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.35M shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.